Autopsy report · NCT04297319

The Use of Laser in the Treatment of Atrophic Vulvovaginitis

“This protocol was cancelled due to the COVID pandemic restrictions in our country. It was imposible to complete the recruitment of patients to achive the study objectives.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months after it had already started.
• Ran for about 2 years 2 months before it stopped.
• 20 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Hospital Italiano de Buenos Aires

Sponsor type

University, hospital or other

Conditions

Lasers; Atrophy of Vagina; Atrophy Vulva

Interventions

Laser diiodo; Laser Placebo

Participants

20

Sites

1

Countries

Argentina

Trials that died the same way

• A Phase 1/2 Study to Assess the Safety, Tolerability and Pharmacokinetics of NGM621 in Healthy Subjects, and to Assess the Safety, PK and Efficacy in Subjects With Moderate to Severe ARDS Caused by COVID-19
  “Due to the rapidly changing therapeutic landscape in the COVID-19 space and an assessment of unmet medical need, Part 2 of the study was cancelled (per protocol Section 4.3). Meanwhile, Part 1 of the study was completed.” (76% match in meaning)
• Riociguat in Patients With Operable CTEPH Prior to Pulmonary Endarterectomy (PEA Bridging Study)
  “The study was stopped due to slower than expected recruitment and the additional limitations on clinical research imposed by the COVID-19 pandemic, both of which made study completion within a reasonable timeframe appear unlikely.” (74% match in meaning)
• A Study of Pleiotropic Pioglitazone Effects on the Alcoholic Lung (APPEAL Study)
  “Study was suspended in 2020 due to COVID-19 pandemic as a result of recruitment challenges and the inability to conduct all study procedures (e.g., bronchoscopy) per protocol. In late 2021 the decision was made to not re-open the study.” (73% match in meaning)
• Clinical Efficacy of Intense Pulsed Light(IPL) Procedure in Dry Eye Patient
  “Due to the covid 19, patient recruiment is not going smoothly, so the study was canceled.” (73% match in meaning)
• Neoadjuvant and Adjuvant Nivolumab in HCC Patients Treated by Electroporation
  “Because patient recruitment was affected by the COVID-19 pandemic, the study sponsor and funding partner halted enrollment at that time to meet contractual obligations” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.